🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07363564
Starting soon Observational

The Prevalence of Hand Joint Hypermobility and Its Relationship With Grip Strength Among University Students.

NCT07363564 · tracked via the Priya Life Science Egypt tracker
Sponsor
Ehab A. Abdallah
Phase
Observational
Started
2026-01-01
Last updated
2026-01-23

Condition(s) studied

Hand Joint HypermobilityGrip Strength

Investigational drug(s) / intervention(s)

No Interventions

No Interventions: NO INTERVENTION

Study summary

This cross-sectional study investigated the prevalence of hand joint hypermobility among 400 university students and its relationship with hand grip strength. MCP joint mobility was assessed using a universal goniometer, and grip strength was measured with a hand dynamometer. Participants were categorized into mild, moderate, and severe hypermobility groups.

Eligibility

Sex
ALL
Min age
18 Years
Max age
24 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Participants were eligible if they were undergraduate university students enrolled in the 2023/2024 academic year, male or female, aged between 18 and 22 years, and had no previously diagnosed systemic conditions associated with hypermobility (e.g., Ehlers-Danlos syndrome or generalized hypermobility syndrome). Exclusion Criteria: * Participants were excluded if they had a previously diagnosed systemic condition associated with hypermobility, reported musculoskeletal injuries or conditions affecting joint mobility or grip strength at the time of assessment, were unable or unwilling to provide informed consent, had any neurological or chronic disorders that could influence muscle strength or joint range of motion or were outside the specified age range (18-22 years).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Horus University Damietta Da
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07363564 on ClinicalTrials.gov ↗ ← All trials in Egypt